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ABSTRACT 
Objective: This prospective study evaluated whether the Activities-specific Balance 
Confidence (ABC-16) scale and short-form ABC-6 could predict future recurrent falls in 
Parkinson’s disease (PD) and evaluated the robustness of their predictive capacities. 
 
Design: 12-month prospective cohort study 
 
Setting: General community 
 
Participants:  313 PD patients were contacted via neurology clinics and pre-existing databases 
and invited to participate. Of those contacted, 188 did not respond, 22 were not interested and 
4 were deceased. Following screening, a further 18 were excluded; 13 had deep brain 
stimulation surgery; 3 used walking aids; and 2 had poor cognition. The remaining 81 
completed all assessments, but two withdrew before completing the follow-up. 
 
Exposures: Clinical tests were completed to establish symptom severity, balance confidence 
and medical history. Over the subsequent 12 months, participants recorded any falls on daily 
falls calendars, which they returned monthly via reply-paid post. 
 
Main Outcomes: Logistic regression and receiver operating characteristic analyses estimated 
the sensitivities and specificities of the ABC-16 and ABC-6 for predicting future recurrent falls 
in this cohort and ‘leave-one-out’ validations were used to assess their robustness. 
 
Results: Of the 79 who completed the follow-up, 28 fell more than once during the 12-month 
period. Both the ABC-16 and ABC-6 were significant predictors of future recurrent falls and 
moderate sensitivities (ABC-16: 75.0%; ABC-6: 71.4%) and specificities (ABC-16: 76.5%; 
ABC-6: 74.5%) were reported for each tool for cut-off scores of 77.5 and 65.8, respectively.  
 
Conclusions: The results have significant implications and demonstrate that the ABC-16 and 
ABC-6 independently identify patients with Parkinson’s disease at risk of future recurrent falls. 
 
 
Keywords: Parkinson Disease; Fear; Accidental Falls; Risk Assessment 
 
HIGHLIGHTS 
• The ABC-16 and ABC-6 independently predict future falls in Parkinson’s patients 
• Cut-offs of 77.5 (ABC-16) and 65.8 (ABC-6) provided the best predictive values 
• Assessing fear of falling in the clinic would help identify ‘high risk’ patients  
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Parkinson’s disease (PD) is characterised by complex symptoms that impair physical function 
and increase the risk of recurrent falls1. Nearly 65% of people with PD report falling at least 
once each year, while up to 50% experience recurrent falls2-4. The increased prevalence of 
falls is compounded by impaired postural responses5 that increase the risk of falls-related 
injuries, injury-related deaths and hospitalisation6. While fall-related injuries often receive 
considerable attention, the psychological consequences of falling are equally disabling and 
cannot be overlooked7.  Specifically, frequent falls contribute to reduced balance confidence 
and an increased fear of future falls, which restricts one’s physical activities and ultimately 
reduces independence and quality of life. 
 
The 16-item Activities-specific Balance Confidence scale (ABC-16) has been widely-adopted 
to assess balance confidence in people with PD, but the need to accurately and rapidly assess 
patient risk in clinical practice often requires more time-efficient tools. Despite being shorter, 
the 6-item ABC (ABC-6) has similar properties to the ABC-16 and, therefore, may be useful 
for assessing balance confidence in PD8. While the Chinese translation of the ABC-16 (ABC-
C) has been shown to independently predict future recurrent fallers in people with PD7, it is 
unclear whether the ABC-16 and ABC-6 are suitable for screening falls risk in PD patients. 
This prospective study aimed to assess whether the ABC-16 and ABC-6 were capable of 
predicting future recurrent falls in people with PD and validated the robustness of their 
predictive capacities. 
 
METHODS 
Study Population 
Seventy-nine people with idiopathic PD based on the UK Brain Bank Criteria9 were recruited 
from neurology clinics and pre-existing patient databases between August 2011 and June 
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2013. Participants were excluded if they had; i) recent surgery; ii) a recurrent history of 
musculoskeletal injury; iii) an inability to walk without assistance; iv) significant visual or 
cognitive impairments; or v) received deep brain stimulation. In accordance with the 
Declaration of Helsinki, participants provided written informed consent and the protocol was 
approved by the Australian Catholic University Ethics Committee (Approval #Q2011 04). 
 
Clinical Assessment 
Participants completed questionnaires and clinical assessments to establish their medical 
history, symptom severity and balance confidence. Specifically, symptom severity was 
assessed using the Freezing of Gait questionnaire, Unified PD Rating Scale (UPDRS), Hoehn 
& Yahr stage score and Schwab and England Activities of Daily Living scale. The UPDRS is 
a universally-accepted clinical test comprising four sub-scales that assess; i) changes in 
mentation, behaviour or mood; ii) difficulties with activities of daily living; iii) impairments 
in motor function; and iv) therapeutic complications.  The Hoehn and Yahr stage score 
assesses the stage of PD based on the severity and distribution of symptoms, with higher 
scores reflecting a more advanced disease state.  Postural instability and gait difficulties 
(PIGD) were quantified by summing the scores for items 13 to 15 and 27 to 30 from the 
UPDRS and the ABC-16 and ABC-6 evaluated balance confidence.  Patients were assessed 
within 1 to 2 hours of taking their anti-parkinsonian medication (Table 1). 
 
Insert Table 1 about here. 
 
12-Month Prospective Follow-up 
Following clinical evaluation, participants recorded any falls experienced over the subsequent 
year on daily falls calendars that they returned monthly via reply-paid post. To minimise 
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attrition, participants were posted a reminder if one of the calendars was not returned.  A fall 
was defined as “an unintentional coming to the ground or some lower level not as a result of a 
major intrinsic event or overwhelming hazard”6. 
 
Statistical Analysis 
Independent samples t-tests were used to assess differences between groups for continuous 
measures of demographics, symptom severity and balance confidence. Where the 
assumptions of parametric statistics were violated, the non-parametric Mann-Whitney U test 
was used. The chi-square (χ2) test was used to evaluate associations between the categorical 
variables. 
 
To determine whether the ABC-16 and ABC-6 could predict future recurrent falls in PD, the 
sensitivities and specificities of these assessments were evaluated using logistic regression 
and receiver operating characteristic (ROC) analyses. The best cut-off score for each was 
considered to be optimal in providing the highest sensitivity and specificity pairing on the 
ROC curves. To assess the efficacy of the ABC-16 and ABC-6 to predict future falls in other 
samples, a ‘leave-one-out’ validation was included.  Significance was set at p<0.05 and all 
statistical procedures were conducted using SPSS 21 and the R statistics package.  
 
RESULTS 
Of the 313 patients contacted, 188 did not respond, 22 were not interested and 4 were 
deceased. A further 18 were excluded following screening; 13 had deep brain stimulation 
surgery; 3 used a walking aid; and 2 had poor cognition. The remaining 81 completed all 
assessments, but two did not complete the follow-up. Based on prospective falls, participants 
were divided into two groups that included; i) 28 participants (35%) who reported more than 
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one fall during the 12-month period (recurrent fallers); and ii) 51 participants (65%) who 
experienced one or fewer falls during this period (non-recurrent fallers). Compared with non-
recurrent fallers, recurrent fallers had significantly longer disease duration, took larger 
amounts of levodopa and experienced greater difficulties with daily activities, physical 
function and mobility (Table 1). Furthermore, recurrent fallers typically presented with 
symptoms of more advanced PD, had less balance confidence and experienced more previous 
falls and therapeutic complications (e.g. dyskinesia) according to the UPDRS IV. 
 
The logistic regression analyses indicated that the ABC-16 (OR: 0.95; 95% CI: 0.92-0.98) 
and ABC-6 (OR: 0.96; 95% CI: 0.94-0.99) were both significant predictors of recurrent falls 
in PD. Furthermore, ROC analyses indicated that a cut-off score of 77.5 provided the best 
sensitivity (75.0%) and specificity (76.5%) for predicting future falls with the ABC-16 
(Figure 1A), while 65.8 provided the best sensitivity (71.4%) and specificity (74.5%) for the 
ABC-6 (Figure 1B). Validation of the models marginally reduced the area under the curve for 
the ABC-16 (Figure 1C) and ABC-6 (Figure 1D) and the specificity of the ABC-6 (70.6%).  
 
Insert Figure 1 about here. 
 
DISCUSSION 
This is the first study to establish that the ABC-16 and ABC-6 can independently predict 
future recurrent falls in people with PD.  The optimal cut-off scores for the ABC-16 
(77.5/100) and ABC-6 (65.8/100) produced moderate to high sensitivities and specificities 
and the validation suggested that both models were robust. However, it is important to note 
that these cut-offs were chosen based on the best combinations of sensitivity and specificity, 
hence, different cut-off scores should be considered if minimizing the likelihood of 
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misclassifying ‘high-risk’ patients is important. For example, a cut-off of 85.9 on the ABC-16 
yielded a sensitivity and specificity of 85.7% and 52.9%, while a score of 77.5 on the ABC-6 
increased sensitivity to 82.1%, but reduced specificity to 51.0%. 
 
Interestingly, our cut-offs were higher than previous research concerning the ABC-C7, which 
demonstrated that a score of 68.4 predicted future recurrent fallers with a sensitivity and 
specificity of 87% and 68%. This discrepancy is likely related to two factors; i) the ABC-C 
modified 4 questions on the ABC-16 that were considered irrelevant for Chinese people10; 
and ii) all recurrent fallers assessed with the ABC-C had previously fallen7 (compared with 
71% in the current study). This higher percentage of previous fallers would likely exacerbate 
fear of future falls for these individuals (i.e. lower balance confidence). Given this point, our 
results may be limited to the English versions of the ABC-16 and ABC-6 and to people with 
PD living independently in the community. 
 
It is important to consider that the transferability of these findings may be limited as only 
25% of the invited patients agreed to participate. While it was not possible to compare 
symptom severity or balance confidence between the included patients and those who 
declined or did not respond, comparison of the groups for age (p=0.765), gender distribution 
(p=0.586) and proximity to the testing location (p=0.512) showed no significant differences. 
Despite these results suggesting that the sample was somewhat representative of the wider 
PD community in this geographical region, it is possible that the reported cut-off scores may 
not be suitable for all PD populations.  
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Nonetheless, these results are clinically significant and demonstrate that the ABC-16 and 
short-form ABC-6 are suited to not only assessing balance confidence in people with PD, but 
can also independently predict future recurrent falls in this population. 
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FIGURE CAPTION 
Figure 1: Receiver operating characteristic (ROC) plots for the; A) 16-item Activities-
specific Balance Confidence scale (ABC-16); B) 6-item Activities-specific Balance 
Confidence scale (ABC-6); C) the leave-one-out validation of the ABC-16; and D) the leave-
one-out validation of the ABC-6. 
 
TABLE CAPTIONS 
Table 1: Demographic data, balance confidence and disease-specific scores for the 
participants with Parkinson’s disease and the recurrent faller and non-recurrent faller sub-
groups. Data represent the mean (and standard error of the mean (SEM)) values or absolute 
numbers and percentages.  
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Tables 
  All Patients Recurrent Faller Non Recurrent Faller   
 (n = 79) (n = 28) (n = 51)   
 
 Mean (SEM) or N (%) 
Mean (SEM) 
or N (%) 
Mean (SEM) 
or N (%) Test p-value 
Demographics      
Age (years) 68.1 (0.9) 69.5 (1.6) 67.3 (1.1) 1 0.250 
Gender (male) 51 (64.6%) 20 (71.4%) 31 (60.8%) 2 0.344 
Height (cm) 168.2 (1.0) 167.2 (1.7) 168.8 (1.2) 1 0.451 
Mass (kg) 74.3 (1.8) 70.3 (2.9) 76.5 (2.2) 1 0.097 
Body Mass Index (kg/m2) 26.1 (0.5) 25.1 (0.9) 26.7 (0.7) 1 0.134 
 Falls History and Balance Confidence      
16-item ABC scale 77.5 (1.9) 67.9 (3.1) 82.8 (2.1) 3 <0.001 
6-item ABC scale 67.2 (2.6) 55.4 (4.0) 73.7 (3.0) 3 <0.001 
Previous Falls (12 months) 3.3 (1.4) 8.5 (3.8) 0.5 (0.1) 3 <0.001 
 Neurological Exam      
Disease Duration (years) 6.1 (0.5) 8.4 (1.0) 4.8 (0.5) 3 0.006 
Levodopa (mg/day) 655.7 (47.5) 876.7 (83.3) 534.4 (50.7) 3 0.001 
Dopamine Agonists 30 (38.0%) 12 (42.9%) 18 (35.3%) 2 0.508 
Catechol-O-Methyl Transferase Inhibitors 28 (35.4%) 13 (46.4%) 15 (29.4%) 2 0.130 
Monoamine Oxidase Inhibitors 12 (15.2%) 4 (14.3%) 8 (15.7%) 2 0.868 
Benzodiazepine 4 (5.1%) 4 (14.3%) 0 (0.0%) 2 0.006 
No Anti-Parkinsonian Medication 5 (6.3%) 0 (0.0%) 5 (9.8%) 2 0.087 
UPDRS I 3.2 (0.2) 3.4 (0.4) 3.0 (0.2) 3 0.341 
UPDRS II 11.3 (0.6) 14.0 (1.1) 9.8 (0.6) 3 0.003 
UPDRS III 20.2 (1.0) 25.1 (1.5) 17.6 (1.2) 1 <0.001 
UPDRS IV 3.9 (0.3) 5.0 (0.7) 3.4 (0.3) 3 0.035 
UPDRS Total 34.7 (1.5) 42.5 (2.5) 30.4 (1.6) 1 <0.001 
PIGD Score 4.7 (0.4) 6.3 (0.7) 3.7 (0.3) 3 0.003 
Freezing of Gait 5.8 (0.6) 9.1 (1.0) 4.0 (0.5) 3 <0.001 
Hoehn & Yahr Stage Score 1.9 (0.1) 2.4 (0.1) 1.6 (0.1) 3 <0.001 
Schwab & England ADL Scale 80.9 (1.1) 74.6 (1.8) 84.3 (1.1) 3 <0.001 
  ABC: Activities-specific Balance Confidence; UPDRS: Unified Parkinson’s Disease Rating Scale; PIGD: Postural 
Instability and Gait Disability; ADL: Activities of Daily Living 
N.B. Test 1 = Independent samples t-test; Test 2 = χ2 test; Test 3 = Mann-Whitney U test 
  
Table 1.  
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C) D)
Cut-off scores and corresponding sensitivities and specificities for the ABC-16 and ABC-6 
ABC-16  ABC-6 
Cut-off Score Sensitivity Specificity  Cut-off Score Sensitivity Specificity 
65.9 42.8 88.2  52.5 50.0 82.4 
77.5 75.0 76.5  65.8 71.4 74.5 
85.9 85.7 52.9  77.5 82.1 51.0 
 
